| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |